ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1802

$551K Total Retail Price of All Prescriptions

Rank: 68 out of 1802

318 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 8,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 380 322 1 2
SIMVASTATIN 379 348 2 1
WARFARIN SODIUM 347 317 3 7
LISINOPRIL 339 306 4 3
FUROSEMIDE 323 263 5 5
HYDROCODONE-ACETAMINOPHEN 306 212 S3 6 10
SERTRALINE HCL 268 241 7 20
OMEPRAZOLE 224 199 8 4
METOPROLOL SUCCINATE 214 184 9 13
AMLODIPINE BESYLATE 213 194 10 6
POTASSIUM CHLORIDE 177 156 11 15
METOPROLOL TARTRATE 170 151 12 9
ATORVASTATIN CALCIUM 150 125 13 14
NAMENDA 150 150 13 34
ALENDRONATE SODIUM 141 141 15 21
ALLOPURINOL 126 114 16 24
CLOPIDOGREL 125 106 17 48
TAMSULOSIN HCL 123 96 18 28
LOSARTAN POTASSIUM 120 111 19 18
HYDROCHLOROTHIAZIDE 118 113 20 8
DONEPEZIL HCL 117 117 21 26
DIOVAN 115 103 22 57
CARVEDILOL 108 76 23 36
MIRTAZAPINE 106 106 24 38
PANTOPRAZOLE SODIUM 99 83 25 44
TRIAMTERENE-HCTZ 98 96 26 49
LANTUS 90 84 27 47
NEXIUM 89 85 28 50
SPIRONOLACTONE 87 75 29 53
TRAMADOL HCL 87 49 29 22
CITALOPRAM HBR 83 74 31 17
METFORMIN HCL 77 73 32 11
GABAPENTIN 76 64 33 16
DIGOXIN 74 74 34 45
IPRATROPIUM-ALBUTEROL 70 70 35 97
PRAVASTATIN SODIUM 68 54 36 19
ZOLPIDEM TARTRATE 68 52 36 27
EXELON 67 67 38 170
PLAVIX 67 59 38 81
ENALAPRIL MALEATE 64 56 40 40
RANITIDINE HCL 64 64 40 30
OXYCODONE-ACETAMINOPHEN 60 40 S2 42 67
ZETIA 58 35 43 79
QUETIAPINE FUMARATE 56 47 44 54
ATENOLOL 55 43 45 12
POLYETHYLENE GLYCOL 3350 54 47 46 29
ADVAIR DISKUS 54 42 46 32
SOTALOL 54 54 46 336
CRESTOR 53 39 49 31
ACETAMINOPHEN-CODEINE 52 49 S3 50 85
GLIPIZIDE XL 50 37 51 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.